omeprazole has been researched along with Neuroendocrine Tumors in 4 studies
Omeprazole: A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
omeprazole : A racemate comprising equimolar amounts of (R)- and (S)-omeprazole.
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole : A member of the class of benzimidazoles that is 1H-benzimidazole which is substituted by a [4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl group at position 2 and a methoxy group at position 5.
Neuroendocrine Tumors: Tumors whose cells possess secretory granules and originate from the neuroectoderm, i.e., the cells of the ectoblast or epiblast that program the neuroendocrine system. Common properties across most neuroendocrine tumors include ectopic hormone production (often via APUD CELLS), the presence of tumor-associated antigens, and isozyme composition.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Familiar, C | 1 |
| Antón, T | 1 |
| Moraga, I | 1 |
| Ramos, A | 1 |
| Marco, A | 1 |
| Giusti, M | 1 |
| Sidoti, M | 1 |
| Augeri, C | 1 |
| Rabitti, C | 1 |
| Minuto, F | 1 |
| Hammond, PJ | 1 |
| Bloom, SR | 1 |
| Waldum, HL | 1 |
| Brenna, E | 1 |
1 review available for omeprazole and Neuroendocrine Tumors
| Article | Year |
|---|---|
[About a case of multiple endocrine neoplasia type 1. Review of some clinical manifestations and treatment controversies].
Topics: Adenoma; Adrenal Gland Neoplasms; Adult; Carcinoid Tumor; Combined Modality Therapy; Duodenal Neopla | 2011 |
3 other studies available for omeprazole and Neuroendocrine Tumors
| Article | Year |
|---|---|
Effect of short-term treatment with low dosages of the proton-pump inhibitor omeprazole on serum chromogranin A levels in man.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Chromogranin A; Chromogranins; Enzyme | 2004 |
Gut neuroendocrine tumors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dacarbazine; Diazoxide; Etoposide; Fluoro | 1994 |
Omeprazole tolerability.
Topics: Adenocarcinoma; Animals; Humans; Neuroendocrine Tumors; Omeprazole; Rats; Stomach Neoplasms | 1994 |